(607) 227-8695info@prendismo.com

Bryan Pearce Discusses Average Duration of VC Investment In Biotech Companies Before Exit

Copyright © Cornell University Play All Videos in Case

Total Case Duration :

  • Date Added : 4/4/2006
  • Clip Duration : 1 min. 20 sec.

Playlists

Please Login to create playlists

Bryan Pearce

  • Partner, Ernst & Young
  • male
  • Caucasian
  • 1963 (Age: 61 years old)
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • Video 1 of 9 in this Case
  • View All Available Videos

Biography

Bryan Pearce is a partner in the technology and life sciences practice of the firm, based in Boston MA, where he leads the firm's New England Venture Capital Advisory Group ("VCAG"). VCAG focuses on development and delivery of value added services to the venture capital industry, including core audit and tax services as well as deal flow, knowledge and thought leadership, and access to our alumni and extended enterprise networks and perspective on current venture capital fundraising trends. In addition, Bryan spends a substantial portion of his time with Emerging Growth companies providing counsel in the areas of fundraising, business models, preparing for a liquidity event, etc. He also is a member of the Global Steering Committee for this important component of the Global E&Y strategy.

Bryan began his career with the firm in 1981 after graduating from the Ivey School of Business at the University of Western Ontario (Canada) and obtained his Canadian Chartered Accountant designation in 1983. Between 1995 and 2000 Bryan was seconded to the Caribbean practice, based in Barbados, where he was responsible for developing and running the Caribbean firm's Corporate Finance and Entrepreneurial Services' practice.

And the final two things that I wanted to just give you an idea from the data is you know how long does this take ... you know once you start the company, how long are you going to be signing up for, is this a 2-year program until you can sell or is it a 10-year program and certainly the data which ...(Full transcript available to logged in subscribers.).

Register & Subscribe Login

Bryan Pearce videos

Video 1 of 9 Bryan Pearce Provides Overview of VC Funding Environment Within Biotech Sector
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Bryan Pearce
  • 4 min. 20 sec.
Video 2 of 9 Bryan Pearce Discusses Where New VC Money Is Going Within Biotech Sector
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Bryan Pearce
  • 1 min. 34 sec.
Video 3 of 9 Bryan Pearce Shares Thoughts on How Much Money A Biotech Startup Should Raise
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Bryan Pearce
  • 2 min. 44 sec.
Video 4 of 9 Bryan Pearce Outlines VC Exit Strategy For Biotech Firms In 2005
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Bryan Pearce
  • 0 min. 51 sec.
Video 5 of 9 Bryan Pearce Discusses Average Duration of VC Investment In Biotech Companies Before Exit
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Bryan Pearce
  • 1 min. 20 sec.
Video 6 of 9 Bryan Pearce States M&A Activity Within Biotech Sector Has Increased
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Bryan Pearce
  • 0 min. 54 sec.
Video 7 of 9 Bryan Pearce Discusses Reasons For Aligning With Partner
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Bryan Pearce
  • 1 min. 2 sec.
Video 8 of 9 Bryan Pearce Discusses Sources of Initial Funding For Biotech Startups
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Bryan Pearce
  • 1 min. 44 sec.
Video 9 of 9 Bryan Pearce Discusses Alternative Sources of Funding For Biotech Startups
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Bryan Pearce
  • 1 min. 28 sec.

RELATED VIDEOS

Bryan Pearce Provides Overview of VC Funding Environment Within Biotech Sector
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Bryan Pearce
  • 4 min. 20 sec.
Bryan Pearce Discusses Where New VC Money Is Going Within Biotech Sector
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Bryan Pearce
  • 1 min. 34 sec.
Bryan Pearce Shares Thoughts on How Much Money A Biotech Startup Should Raise
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Bryan Pearce
  • 2 min. 44 sec.
Bryan Pearce Outlines VC Exit Strategy For Biotech Firms In 2005
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Bryan Pearce
  • 0 min. 51 sec.
Bryan Pearce Discusses Average Duration of VC Investment In Biotech Companies Before Exit
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Bryan Pearce
  • 1 min. 20 sec.
Bryan Pearce States M&A Activity Within Biotech Sector Has Increased
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Bryan Pearce
  • 0 min. 54 sec.
Bryan Pearce Discusses Reasons For Aligning With Partner
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Bryan Pearce
  • 1 min. 2 sec.
Bryan Pearce Discusses Sources of Initial Funding For Biotech Startups
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Bryan Pearce
  • 1 min. 44 sec.
Bryan Pearce Discusses Alternative Sources of Funding For Biotech Startups
  • Invention To Venture - April 2006 - Bryan Pearce - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Bryan Pearce
  • 1 min. 28 sec.